A súlyos szepszis kezelésének elso napi költsége az intenzív osztályon a gyógyult és a meghalt betegek összehasonlításában

Translated title of the contribution: Direct cost differences of severe sepsis between survivors and non-survivors on day 1 of intensive care admission

Ákos Csomós, Zoltán Szentkereszty, B. Fülesdi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Patients admitted to intensive care unit with severe sepsis have high mortality and use significant resources. Aims: Determination of variable cost differences on day 1 between survivors and non-survivors of severe sepsis in Hungary. Methods: A sample of 6 intensive care units (ICU) included 70 patients who were admitted with severe sepsis to their ICU. Retrospective data collection of resource consumption for 24 hours following ICU admission using medical and nursing records. 59 different resource uses were collected separately for radiology, biochemistry and disposables. Blood products and drugs/fluids were collected individually. The authors identified the price of each resource for the cost calculation. Results: The ICU mortality of severe sepsis in our sample was found to be 64%, the average length of stay for survivors was 19.9 (SD ± 11.4) and for non-survivors was 13.0 (SD ± 8.5). Mean ICU variable cost on day 1 of severe sepsis was HUF 60 957 (247 Euro), more for non-survivors (HUF 70 835 vs. 40 108, p = 0.020). The use of blood products is higher in non-survivors (p = 0.047) and so is the use of drugs/fluids (p = 0.003). The use of more colloids (p = 0.016) and more expensive antibiotics (p = 0.021) was responsible for the higher drugs/fluids spending in non-survivors. Conclusion: The mortality of severe sepsis is high and the cost of sepsis treatment is low in Hungary compared to international data. Non-survivors cost almost twice as much even on day 1, this warrants the need for early diagnosis and adequate treatment.

Original languageHungarian
Pages (from-to)1851-1856
Number of pages6
JournalOrvosi Hetilap
Volume148
Issue number39
DOIs
Publication statusPublished - Sep 30 2007

Fingerprint

Critical Care
Survivors
Sepsis
Intensive Care Units
Costs and Cost Analysis
Hungary
Mortality
Nursing Records
Pharmaceutical Preparations
Colloids
Radiology
Health Care Costs
Biochemistry
Medical Records
Early Diagnosis
Length of Stay
Anti-Bacterial Agents

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A súlyos szepszis kezelésének elso napi költsége az intenzív osztályon a gyógyult és a meghalt betegek összehasonlításában. / Csomós, Ákos; Szentkereszty, Zoltán; Fülesdi, B.

In: Orvosi Hetilap, Vol. 148, No. 39, 30.09.2007, p. 1851-1856.

Research output: Contribution to journalArticle

@article{5ecbbbab1d364cc082e7026df5b8df75,
title = "A s{\'u}lyos szepszis kezel{\'e}s{\'e}nek elso napi k{\"o}lts{\'e}ge az intenz{\'i}v oszt{\'a}lyon a gy{\'o}gyult {\'e}s a meghalt betegek {\"o}sszehasonl{\'i}t{\'a}s{\'a}ban",
abstract = "Background: Patients admitted to intensive care unit with severe sepsis have high mortality and use significant resources. Aims: Determination of variable cost differences on day 1 between survivors and non-survivors of severe sepsis in Hungary. Methods: A sample of 6 intensive care units (ICU) included 70 patients who were admitted with severe sepsis to their ICU. Retrospective data collection of resource consumption for 24 hours following ICU admission using medical and nursing records. 59 different resource uses were collected separately for radiology, biochemistry and disposables. Blood products and drugs/fluids were collected individually. The authors identified the price of each resource for the cost calculation. Results: The ICU mortality of severe sepsis in our sample was found to be 64{\%}, the average length of stay for survivors was 19.9 (SD ± 11.4) and for non-survivors was 13.0 (SD ± 8.5). Mean ICU variable cost on day 1 of severe sepsis was HUF 60 957 (247 Euro), more for non-survivors (HUF 70 835 vs. 40 108, p = 0.020). The use of blood products is higher in non-survivors (p = 0.047) and so is the use of drugs/fluids (p = 0.003). The use of more colloids (p = 0.016) and more expensive antibiotics (p = 0.021) was responsible for the higher drugs/fluids spending in non-survivors. Conclusion: The mortality of severe sepsis is high and the cost of sepsis treatment is low in Hungary compared to international data. Non-survivors cost almost twice as much even on day 1, this warrants the need for early diagnosis and adequate treatment.",
keywords = "Cost of treatment, Intensive care, Severe sepsis",
author = "{\'A}kos Csom{\'o}s and Zolt{\'a}n Szentkereszty and B. F{\"u}lesdi",
year = "2007",
month = "9",
day = "30",
doi = "10.1556/OH.2007.28055",
language = "Hungarian",
volume = "148",
pages = "1851--1856",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "39",

}

TY - JOUR

T1 - A súlyos szepszis kezelésének elso napi költsége az intenzív osztályon a gyógyult és a meghalt betegek összehasonlításában

AU - Csomós, Ákos

AU - Szentkereszty, Zoltán

AU - Fülesdi, B.

PY - 2007/9/30

Y1 - 2007/9/30

N2 - Background: Patients admitted to intensive care unit with severe sepsis have high mortality and use significant resources. Aims: Determination of variable cost differences on day 1 between survivors and non-survivors of severe sepsis in Hungary. Methods: A sample of 6 intensive care units (ICU) included 70 patients who were admitted with severe sepsis to their ICU. Retrospective data collection of resource consumption for 24 hours following ICU admission using medical and nursing records. 59 different resource uses were collected separately for radiology, biochemistry and disposables. Blood products and drugs/fluids were collected individually. The authors identified the price of each resource for the cost calculation. Results: The ICU mortality of severe sepsis in our sample was found to be 64%, the average length of stay for survivors was 19.9 (SD ± 11.4) and for non-survivors was 13.0 (SD ± 8.5). Mean ICU variable cost on day 1 of severe sepsis was HUF 60 957 (247 Euro), more for non-survivors (HUF 70 835 vs. 40 108, p = 0.020). The use of blood products is higher in non-survivors (p = 0.047) and so is the use of drugs/fluids (p = 0.003). The use of more colloids (p = 0.016) and more expensive antibiotics (p = 0.021) was responsible for the higher drugs/fluids spending in non-survivors. Conclusion: The mortality of severe sepsis is high and the cost of sepsis treatment is low in Hungary compared to international data. Non-survivors cost almost twice as much even on day 1, this warrants the need for early diagnosis and adequate treatment.

AB - Background: Patients admitted to intensive care unit with severe sepsis have high mortality and use significant resources. Aims: Determination of variable cost differences on day 1 between survivors and non-survivors of severe sepsis in Hungary. Methods: A sample of 6 intensive care units (ICU) included 70 patients who were admitted with severe sepsis to their ICU. Retrospective data collection of resource consumption for 24 hours following ICU admission using medical and nursing records. 59 different resource uses were collected separately for radiology, biochemistry and disposables. Blood products and drugs/fluids were collected individually. The authors identified the price of each resource for the cost calculation. Results: The ICU mortality of severe sepsis in our sample was found to be 64%, the average length of stay for survivors was 19.9 (SD ± 11.4) and for non-survivors was 13.0 (SD ± 8.5). Mean ICU variable cost on day 1 of severe sepsis was HUF 60 957 (247 Euro), more for non-survivors (HUF 70 835 vs. 40 108, p = 0.020). The use of blood products is higher in non-survivors (p = 0.047) and so is the use of drugs/fluids (p = 0.003). The use of more colloids (p = 0.016) and more expensive antibiotics (p = 0.021) was responsible for the higher drugs/fluids spending in non-survivors. Conclusion: The mortality of severe sepsis is high and the cost of sepsis treatment is low in Hungary compared to international data. Non-survivors cost almost twice as much even on day 1, this warrants the need for early diagnosis and adequate treatment.

KW - Cost of treatment

KW - Intensive care

KW - Severe sepsis

UR - http://www.scopus.com/inward/record.url?scp=35348870411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35348870411&partnerID=8YFLogxK

U2 - 10.1556/OH.2007.28055

DO - 10.1556/OH.2007.28055

M3 - Article

C2 - 17890173

AN - SCOPUS:35348870411

VL - 148

SP - 1851

EP - 1856

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 39

ER -